The Addition of Inhaled Furosemide to Standard Treatment of COPD Exacerbation
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The goal of this randomized controlled trial is to determine the effect of adding inhaled
furosemide to the known treatment of patient with Chronic obstructive pulmonary disease
(COPD) exacerbation. It primarily aims at studying its effect on:
1. Relief of dyspnea sensation
2. Length of hospital stay
Participants will be receiving the standard therapy of COPD exacerbation plus either inhaled
furosemide or inhaled saline over 3 days. They will be asked to:
- Perform spirometry
- Fill in dyspnea score
- Do arterial blood gases (ABGs)